Who is cosette wheeler

Cancer Epidemiol Biomarkers Prev. Ann Intern Med. Lancet Oncol. PLoS Pathog. PMID: Human papillomavirus testing co-testing and triage utilization and impact on subsequent clinical management. Am J Surg Pathol. PMID: Investigating stakeholder attitudes and opinions on school-based human papillomavirus vaccination programs. J Sch Health.

Those who had been screened in the three years prior to diagnosis were half as likely to be diagnosed with localized cervical cancer as those who hadn't been screened. The team also showed that women who receive a negative screening test were very unlikely to be diagnosed with cervical cancer in the following three-and-a-half to five years.

Many HPV infections will resolve naturally, Wheeler says, but the immune system needs time to act. She and her team found that more frequent screening offered no additional benefit. And the local cancer is easily treatable.

This study, she says, gives real-world evidence to assure New Mexican women and their health care providers that screening for cervical cancer every three years safely finds cancer early and that screening more frequently has no additional benefit. In the end, the biggest problem Wheeler sees is that the United States has no organized way to remind women when the time comes for their three-year screening.

Journal of clinical microbiology 36 10 , , CA: a cancer journal for clinicians 57 1 , , The Journal of infectious diseases 7 , , Journal of Infectious Diseases 5 , , Articles 1—20 Show more. Help Privacy Terms. The lancet , , The lancet oncology 6 5 , , The Lancet , , Cosette M. Wheeler, Ph.